Short Interest in Syra Health Corp. (NASDAQ:SYRA) Increases By 63.2%

Syra Health Corp. (NASDAQ:SYRAGet Free Report) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 208,200 shares, a growth of 63.2% from the September 30th total of 127,600 shares. Approximately 2.8% of the company’s stock are short sold. Based on an average daily volume of 255,700 shares, the days-to-cover ratio is currently 0.8 days.

Syra Health Price Performance

SYRA stock remained flat at $0.41 during trading on Monday. The company had a trading volume of 57,043 shares, compared to its average volume of 808,304. The company’s 50 day moving average price is $0.64 and its 200 day moving average price is $1.10. Syra Health has a 12 month low of $0.34 and a 12 month high of $8.37. The company has a market capitalization of $2.35 million and a P/E ratio of -0.61.

Syra Health (NASDAQ:SYRAGet Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.02). Syra Health had a negative return on equity of 201.13% and a negative net margin of 59.22%. The firm had revenue of $1.97 million during the quarter, compared to analysts’ expectations of $1.79 million. Equities research analysts expect that Syra Health will post -0.86 earnings per share for the current fiscal year.

About Syra Health

(Get Free Report)

Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions.

Featured Stories

Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.